High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma

Kenneth H. Buetow(Arizona State University), Karen Taraszka Hastings(University of Arizona), Yih‐Kuang Lu(Arizona State University), Haiyan Cui(Tongji University), Hari Menon(All India Institute of Medical Sciences), Jacob Brill(Arizona State University), David J. DiCaudo(Mayo Clinic in Arizona), Lydia R. Meador(University of Arizona), Denise J. Roe(University of Arizona)
The Journal of Immunology
October 7, 2019
Cited by 37


Related Papers